Clinical Trial Details

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

IRB Protocol Number
A032302

Clinical Trial Categories

  • Prostate Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men 18+ years old, with diagnosis of metastatic adenocarcinoma of the prostate without small cell histology, and no prior chemotherapy for prostate cancer. 

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.